Prevalence of cancer in patients with congenital IGF-1 deficiency – request for cooperation

17 Oct 2014


Founding ESPE member Professor Zvi Laron is working on a project to update the previous survey on the prevalence of cancer in patients with congenital IGF-1 deficiency (Laron syndrome (primary GH insensitivity), congenital  IGHD, GHRH-R mutation, IGF-I gene deletion, IGF-1R mutation, congenital MPHD) - Steuerman et al. European Journal of Endocrinology (2011) 164 485–489, DOI: 10.1530/EJE-10-0859.

If you are following any relevant patients please contact us (via email: [email protected]) to receive a simple questionnaire.


Share this story